Featured Research

from universities, journals, and other organizations

New Treatment Holds Promise For Tourette Syndrome

Date:
November 13, 2007
Source:
University Hospitals of Cleveland
Summary:
Deep brain stimulation helps patients who suffer from Tourette Syndrome, according to a new article. This first-of-its-kind study of five adults with TS determined that DBS can reduce tic frequency and severity in some people who have exhausted other medical treatments. The majority of patients experienced a significant reduction in symptoms and an improved quality of life.

Research out of the Neurological Institute at University Hospitals Case Medical Center finds that Deep Brain Stimulation (DBS) helps patients who suffer from Tourette Syndrome (TS). This first-of-its-kind study of five adults with TS determined that DBS can reduce tic frequency and severity in some people who have exhausted other medical treatments.

Tourette syndrome is a neurobehavioral disorder characterized by sudden, repetitive muscle movements (motor tics) and vocalizations (vocal tics). It often begins in childhood. By young adulthood the tics have usually diminished in frequency and severity. However, in some adults, like those that participated in this clinical trial, the tics become more disabling even with best medical therapy.

The UHCMC team's prospective double-blind study followed these five adults with TS over the course of 12 months. The 3-month data are published in the November issue of the Journal of Neurosurgery. The team concluded that the majority of patients experienced a significant reduction in symptoms and an improved quality of life. The study followed their landmark case in 2004 when the UHCMC neurological team used DBS to treat a 31-year-old man with Tourette Syndrome. Once his deep brain stimulators were turned on he had an immediate and nearly complete resolution of his symptoms.

"This is this first and only careful scientific surgical trial for Tourette Syndrome, and provides the highest level of data showing that this surgery is proven to be significantly beneficial for medically refractory Tourette," says Robert Maciunas, MD, Vice Chairman and Professor of Neurological Surgery at UHCMC and lead author of the paper. "This study promises to change the standard of care for patients who fail to respond to traditional medications. It promises to usher in a new era of medical research and treatment for Tourette Syndrome with DBS," he says.

DBS is approved by the Food and Drug Administration for treatment of Parkinson's disease, essential tremor and dystonia. DBS involves the surgical implantation of electrodes in the brain and pulse generators in the upper chest just beneath the collarbones. The implanted pulse generator (IPG) is connected to the electrode in the brain by a thin cable that is placed under the skin. The IPG is then programmed to deliver a high-frequency electrical stimulation to the targeted area of the brain.

In this double-blind study the electrodes were placed in the thalamus, a portion of the brain that is involved in controlling movement. Prior to surgery the neurologic team at UHCMC mapped out regions of the patients' brains using MRI (magnetic resonance imaging) scans and 3-D computer images. Their goal was to locate the safest and most direct route to reach the thalamus. Following surgery the researchers conducted double-blind video-based rating assessments of tic frequency and severity. They found that three of five patients had a marked reduction in their motor and vocal tics and all but one patient had a significant improvement in quality of life.

"Deep Brain Stimulation has been used to successfully treat certain movement disorders for years," says David Riley, MD, Director of the UH Movement Disorders Center and Professor of Neurology at Case Western Reserve University. "We carefully studied its use in these five patients suffering from refractory Tourette Syndrome and found that it significantly reduced the tics in most of the patients and improved their quality of life."

"The use of DBS for Tourette syndrome is still an emerging area of study but in this first of its kind clinical trial, our team found that DBS has good potential to be a viable treatment for people with this potentially debilitating syndrome," says Christina Whitney, DNSc, RN, clinical nurse specialist in the movement disorders center. "The treatment was found to be safe and we plan to conduct a larger clinical trial to further determine its efficacy in helping patients who have failed traditional medical therapy for Tourette syndrome."


Story Source:

The above story is based on materials provided by University Hospitals of Cleveland. Note: Materials may be edited for content and length.


Cite This Page:

University Hospitals of Cleveland. "New Treatment Holds Promise For Tourette Syndrome." ScienceDaily. ScienceDaily, 13 November 2007. <www.sciencedaily.com/releases/2007/11/071112105935.htm>.
University Hospitals of Cleveland. (2007, November 13). New Treatment Holds Promise For Tourette Syndrome. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2007/11/071112105935.htm
University Hospitals of Cleveland. "New Treatment Holds Promise For Tourette Syndrome." ScienceDaily. www.sciencedaily.com/releases/2007/11/071112105935.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins